Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01152970
Other study ID # DA024646 01A2
Secondary ID R01DA024646-01A2
Status Completed
Phase N/A
First received June 28, 2010
Last updated August 8, 2016
Start date November 2009
Est. completion date December 2013

Study information

Verified date August 2016
Source University of Michigan
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

The provision of medical services in an inner city Emergency Department (ED) provides a critical opportunity to identify and characterize future timing and pattern of service use among youth with drug use, who may be missed in school-based samples, and who may not yet be in the criminal justice system. Currently, there is a paucity of data on the timing, pattern, barriers, and trajectory of youth with multiple risks (illicit drug use and ED visit for acute violence related injury) in terms of their intersection with health services (substance use treatment, mental health, medical) and criminal justice system, which limits the development of optimal timing and setting for interventions. Youth treated in the ED may have exacerbated rates of illicit drug use, and other risk behaviors (i.e. delinquency, HIV risk behaviors, weapon carriage) and different trajectories of outcomes and interactions with service use sectors based on presentation for intentional injury as compared to other complaints (medical, unintentional injuries). Understanding the outcomes and service utilization among inner-city youth with drug use with and without acute violent injury is critically important in developing prevention and treatment services to address these multiple risk factors. The investigators propose a prospective observational study over a two-year period to identify a high risk group of youth with past year illicit drug use (N=650) seeking care in an inner city ED. The specific aims of the study, chosen to obtain data necessary to determine the location and content of subsequent interventions, are: (1) To describe characteristics of youth (ages 14-24; n=650) who report illicit drug use presenting to an urban ED for an acute violent injury (n=350), compared to youth with drug use who seek non-violence related ED care (n=300), including demographic characteristics, problem severity (e.g., substance use, violence, HIV risk behaviors, etc.), enabling factors, and service utilization (i.e., substance use treatment, mental health, and medical); (2) To identify the trajectories of participants' interactions with health services during the two years following their ED visit and the key characteristics (i.e., predisposing, enabling, and need factors) associated with types of service use (substance abuse treatment, mental health, and medical/ ED) and barriers to these services; and, (3) To measure two-year outcomes for this cohort and to identify key demographic and clinical characteristics of youth with drug use, who have poor outcomes in the two years after ED visit for intentional injury and other medical care.


Recruitment information / eligibility

Status Completed
Enrollment 638
Est. completion date December 2013
Est. primary completion date October 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 14 Years to 24 Years
Eligibility Inclusion Criteria:

Inclusion criteria for screening:

1. youth (ages 14-24) presenting to the Hurley Medical Center (HMC) ED who are medically stable. Patients classified by medical staff as having unstable vital signs or "Level 1" trauma (e.g., unconscious, in need of immediate lifesaving procedures such as surgery), will be approached during their inpatient stay after stabilization (4% based on prior work);

2. access to a parent or guardian for consent among adolescents ages 14-17 (over 90% based on our prior work).

Positive substance use screen criteria: Youth will be eligible for the longitudinal study if they endorse on self-report computer survey past year use of illicit drugs (e.g. marijuana, cocaine, inhalants, non-prescribed use of psychoactive prescription drugs, etc).-

Exclusion Criteria:

1. youth who do not understand English

2. youth deemed unable to provide informed assent/consent by ED or research staff

3. prisoners at time of ED presentation.

4. youth who present to the ED as victims of sexual abuse or child abuse -

Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
United States Hurley Medical Center Emergency Department Flint Michigan

Sponsors (2)

Lead Sponsor Collaborator
University of Michigan National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary substance use as assessed with both the Mini-International Neuropsychiatric Interview Change from baseline substance use at 24 month No
Primary substance use as assessed with the National Institute on Drug Abuse- Modified Alcohol, Smoking and Substance Involvement Screening Test Change from baseline substance use at 24 month No
Primary violence behaviors as assessed with the modified Conflict Tactic Scale Change from baseline violence behaviors at 24 month No
Primary HIV risk behaviors as assessed with the Risk Assessment Battery Change from baseline HIV risk behaviors at 24 month No
Primary trajectories of participants' interactions with health services during the two years following their ED visit for an acute violent injury or for non-violence related care Services will include substance abuse treatment, mental health services, and medical services including ED recidivism and HIV testing as assessed through chart review through the study completion, over 24 months No
See also
  Status Clinical Trial Phase
Recruiting NCT06020391 - Cooperation for Better Treatment of Polypharmacy in the Community N/A
Completed NCT02490345 - Gabapentin as Adjunctive Treatment for Postoperative Pain Control Phase 1
Completed NCT01931683 - Dosing Study of Remifentanil for Smooth Removal of the Laryngeal Mask Airway (LMA) Phase 4
Withdrawn NCT03938077 - A Community-University Approach to Preventing HIV N/A
Completed NCT02973724 - EC95 of Remifentanil for Preventing Cough N/A
Completed NCT03330782 - Remifentanil for Preventing Propofol Injection Pain in Elderly Patients Phase 4
Completed NCT01489683 - Intubating Conditions During Propofol-remifentanil Anesthesia With Topical Lidocaine N/A
Completed NCT03368456 - Preventing HIV/STI in Urban Adolescents Via an mHealth Primary Care Intervention N/A
Completed NCT02379455 - Cooperation for Improved Pharmacotherapy in Home-dwelling Elderly People Receiving Polypharmacy - The COOP Study N/A
Completed NCT01852539 - Dexmedetomidine for Laryngeal Mask Airway Insertion Phase 4
Completed NCT01963130 - Does Vildagliptin Affect Portal Vein Pressure In Patients With Type 2 Diabetes Mellitus? A Cross Sectional Study N/A
Recruiting NCT01496105 - Efficacy Study of Topical Application of Lidacaine Spray Prior to IUD Insertion Phase 4
Completed NCT02334046 - Remifentanil for Smooth Emergence in Elderly Patients Phase 4
Completed NCT00876941 - Assessing Screening Plus Brief Intervention's Resulting Efficacy (ASPIRE) to Stop Drug Use Phase 3